Intech Investment Management LLC reduced its position in Universal Health Services, Inc. (NYSE:UHS - Free Report) by 37.8% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 58,059 shares of the health services provider's stock after selling 35,235 shares during the period. Intech Investment Management LLC owned about 0.09% of Universal Health Services worth $10,909,000 as of its most recent filing with the SEC.
Several other hedge funds also recently made changes to their positions in the business. Ameriprise Financial Inc. increased its stake in Universal Health Services by 82.8% in the fourth quarter. Ameriprise Financial Inc. now owns 94,275 shares of the health services provider's stock valued at $16,916,000 after acquiring an additional 42,714 shares during the last quarter. Cetera Investment Advisers lifted its holdings in Universal Health Services by 30.6% in the fourth quarter. Cetera Investment Advisers now owns 12,858 shares of the health services provider's stock valued at $2,307,000 after buying an additional 3,011 shares during the period. Deutsche Bank AG increased its stake in Universal Health Services by 53.2% in the fourth quarter. Deutsche Bank AG now owns 255,828 shares of the health services provider's stock valued at $45,901,000 after purchasing an additional 88,835 shares in the last quarter. D. E. Shaw & Co. Inc. increased its stake in Universal Health Services by 99.2% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 12,450 shares of the health services provider's stock valued at $2,234,000 after purchasing an additional 6,200 shares in the last quarter. Finally, Ensign Peak Advisors Inc increased its position in shares of Universal Health Services by 34.9% during the fourth quarter. Ensign Peak Advisors Inc now owns 32,845 shares of the health services provider's stock worth $5,893,000 after acquiring an additional 8,501 shares in the last quarter. 86.05% of the stock is owned by institutional investors.
Universal Health Services Stock Performance
NYSE UHS traded down $0.06 on Tuesday, hitting $189.52. 192,605 shares of the company's stock traded hands, compared to its average volume of 829,860. The company has a current ratio of 1.29, a quick ratio of 1.19 and a debt-to-equity ratio of 0.64. Universal Health Services, Inc. has a 1-year low of $152.33 and a 1-year high of $243.25. The firm's 50-day moving average price is $176.33 and its two-hundred day moving average price is $178.69. The firm has a market capitalization of $12.06 billion, a PE ratio of 9.97, a P/E/G ratio of 0.79 and a beta of 1.28.
Universal Health Services (NYSE:UHS - Get Free Report) last posted its quarterly earnings data on Monday, July 28th. The health services provider reported $5.35 earnings per share for the quarter, topping analysts' consensus estimates of $4.85 by $0.50. Universal Health Services had a net margin of 7.66% and a return on equity of 18.25%. The company had revenue of $4.28 billion during the quarter, compared to analysts' expectations of $4.24 billion. During the same period in the prior year, the business posted $4.31 earnings per share. The firm's revenue for the quarter was up 9.6% on a year-over-year basis. Universal Health Services has set its FY 2025 guidance at 20.000-21.000 EPS. As a group, analysts expect that Universal Health Services, Inc. will post 15.92 EPS for the current year.
Universal Health Services Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 16th. Stockholders of record on Tuesday, September 2nd will be given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend is Tuesday, September 2nd. Universal Health Services's dividend payout ratio is currently 4.21%.
Analyst Upgrades and Downgrades
UHS has been the topic of a number of recent research reports. Stephens upgraded shares of Universal Health Services to a "hold" rating in a research note on Monday, June 2nd. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $227.00 target price on shares of Universal Health Services in a research note on Tuesday, August 26th. Robert W. Baird dropped their target price on shares of Universal Health Services from $243.00 to $203.00 and set a "neutral" rating on the stock in a research note on Thursday, August 14th. JPMorgan Chase & Co. decreased their price objective on shares of Universal Health Services from $215.00 to $195.00 and set a "neutral" rating for the company in a report on Monday, August 4th. Finally, Barclays upped their target price on shares of Universal Health Services from $257.00 to $259.00 and gave the company an "overweight" rating in a report on Wednesday, July 30th. Four investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $214.77.
Read Our Latest Report on Universal Health Services
Universal Health Services Profile
(
Free Report)
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.
Recommended Stories

Before you consider Universal Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Universal Health Services wasn't on the list.
While Universal Health Services currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.